2Collaborative Group on Hormonal Factors in Breast Cancer.Breast cancer and hormone replacement therapy:collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer[J].Lancet,1997
3Ray NF,Chan JK,Thamer M,et al.Medical expenditures for the treatment of osteoporotic fracture in the United States in 1995:Report from the National Osteoporosis Foundation[J].J Bone Miner Res,1997,12:24-35.
4Torgerson DJ,Bell-Syer SE.Hormone replacement therapy and prevention of nonvertebral fractures:a meta-analysis of randomized trials[J].JAMA,2001,285:2891-2897.
5Writing Group for the Women Health Initiative Invesigators.Risk and benefits of estrogrn plus progestin in healthy postmenopausal women[J].JAMA,2002,288:321-333.
6The Writing Group for the PEPI Trial.Effects of hormone therapy of bone mineral density[J].J Am Med Assoc,1996,276:1389-1396.
7Stevenson JC.Do we need different galenic forms of oestrogens and progestogens? In Birkh?user MH,Rozenbaum H eds.Menopause[M].Edition Eska,1996.231-235.
8Gallagher JC,Kable WT.Effect of progestin therapy on cortical and trabecular bone:comparison with estrogen[J].Am J Med,1991,90:171-178.
9Abdalla HI,Hart DM,Lindsay R.Prevention of bone mineral loss in postmenopausal women by norethisterone[J].Obstet Gynecol,1985,66:789-792.
10Kleerekoper M,Blacker C.Hormone replacement therapy for osteoporosis.In Whitehead M eds.The prescriber'guide to Hormone Replacement Threapy[M].The Parthenon Publishing Group,1998.129-140.
